Katherine Marie Deleon, FNP-C

Katherine Deleon practices at Southern California Urgent Care Network in Murrieta, California.

Katherine Deleon's NPI, 1700482452, was assigned on December 8, 2020. Katherine Deleon holds California license 95016202.

Katherine Deleon's primary practice is Southern California Urgent Care Network, at 41880 Kalmia St, Murrieta, CA 92562 in Riverside County. The practice phone is (661) 256-6365.

Katherine Deleon's primary practice is Southern California Urgent Care Network in Murrieta, California. The medical group on file is Rosamond Urgent Care.

Dmand AI tracks the electronic health record (EHR) system at each site where Katherine Deleon practices. Vendor and product names are available with a free account.

Family is Katherine Deleon's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Katherine Deleon is licensed in California.

Dmand AI lists acute sinusitis, acute skin infection, ankle or foot injury, bronchitis, ear infection, fluid in a joint, gastroenteritis and knee injury among the conditions Katherine Deleon treats.

CMS data shows 295 Medicare services from Katherine Deleon across 7 procedure codes in 2024, for 208 Medicare patients. Medicare paid $14,312 for them. Every service was in an office.

CMS counts 208 Medicare patients who saw Katherine Deleon in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Katherine Deleon's median patient age at 34, with 60% women.

In 2024, Katherine Deleon wrote 428 Medicare Part D claims for 290 patients. 94% of them were for generic drugs. CMS names the drug for 308 of them, across 12 drugs with 11 or more claims each, at $2,319 in total drug cost.

Katherine Deleon accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Katherine Deleon from 2 drug and device companies in 2024. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $30.